Johnson DG - Search Results

1

A high-frequency regulatory polymorphism in the p53 pathway accelerates tumor development.

Post SM, Quintás-Cardama A, Pant V, Iwakuma T, Hamir A, Jackson JG, Maccio DR, Bond GL, Johnson DG, Levine AJ, Lozano G. Post SM, et al. Among authors: johnson dg. Cancer Cell. 2010 Sep 14;18(3):220-30. doi: 10.1016/j.ccr.2010.07.010. Cancer Cell. 2010. PMID: 20832750 Free PMC article.

2

Inactivation of E2f1 enhances tumorigenesis in a Myc transgenic model.

Rounbehler RJ, Rogers PM, Conti CJ, Johnson DG. Rounbehler RJ, et al. Among authors: johnson dg. Cancer Res. 2002 Jun 1;62(11):3276-81. Cancer Res. 2002. PMID: 12036945

3

E2F1 uses the ATM signaling pathway to induce p53 and Chk2 phosphorylation and apoptosis.

Powers JT, Hong S, Mayhew CN, Rogers PM, Knudsen ES, Johnson DG. Powers JT, et al. Among authors: johnson dg. Mol Cancer Res. 2004 Apr;2(4):203-14. Mol Cancer Res. 2004. PMID: 15140942

4

E2F1 suppresses skin carcinogenesis via the ARF-p53 pathway.

Russell JL, Weaks RL, Berton TR, Johnson DG. Russell JL, et al. Among authors: johnson dg. Oncogene. 2006 Feb 9;25(6):867-76. doi: 10.1038/sj.onc.1209120. Oncogene. 2006. PMID: 16205640

5

Expression of transcription factor E2F1 and telomerase in glioblastomas: mechanistic linkage and prognostic significance.

Alonso MM, Fueyo J, Shay JW, Aldape KD, Jiang H, Lee OH, Johnson DG, Xu J, Kondo Y, Kanzawa T, Kyo S, Bekele BN, Zhou X, Nigro J, McDonald JM, Yung WK, Gomez-Manzano C. Alonso MM, et al. Among authors: johnson dg. J Natl Cancer Inst. 2005 Nov 2;97(21):1589-600. doi: 10.1093/jnci/dji340. J Natl Cancer Inst. 2005. PMID: 16264179

6

E2F3a stimulates proliferation, p53-independent apoptosis and carcinogenesis in a transgenic mouse model.

Paulson QX, McArthur MJ, Johnson DG. Paulson QX, et al. Among authors: johnson dg. Cell Cycle. 2006 Jan;5(2):184-90. doi: 10.4161/cc.5.2.2307. Epub 2006 Jan 16. Cell Cycle. 2006. PMID: 16340309 Free article.

7

Oncogenes and the DNA damage response: Myc and E2F1 engage the ATM signaling pathway to activate p53 and induce apoptosis.

Hong S, Pusapati RV, Powers JT, Johnson DG. Hong S, et al. Among authors: johnson dg. Cell Cycle. 2006 Apr;5(8):801-3. doi: 10.4161/cc.5.8.2638. Epub 2006 Apr 17. Cell Cycle. 2006. PMID: 16582589

8

Transgenic E2F1 expression in the mouse brain induces a human-like bimodal pattern of tumors.

Olson MV, Johnson DG, Jiang H, Xu J, Alonso MM, Aldape KD, Fuller GN, Bekele BN, Yung WK, Gomez-Manzano C, Fueyo J. Olson MV, et al. Among authors: johnson dg. Cancer Res. 2007 May 1;67(9):4005-9. doi: 10.1158/0008-5472.CAN-06-2973. Cancer Res. 2007. PMID: 17483310

9

Mouse models for the p53 R72P polymorphism mimic human phenotypes.

Zhu F, Dollé ME, Berton TR, Kuiper RV, Capps C, Espejo A, McArthur MJ, Bedford MT, van Steeg H, de Vries A, Johnson DG. Zhu F, et al. Among authors: johnson dg. Cancer Res. 2010 Jul 15;70(14):5851-9. doi: 10.1158/0008-5472.CAN-09-4646. Epub 2010 Jun 29. Cancer Res. 2010. PMID: 20587514 Free PMC article.

10

The RB-E2F1 pathway regulates autophagy.

Jiang H, Martin V, Gomez-Manzano C, Johnson DG, Alonso M, White E, Xu J, McDonnell TJ, Shinojima N, Fueyo J. Jiang H, et al. Among authors: johnson dg. Cancer Res. 2010 Oct 15;70(20):7882-93. doi: 10.1158/0008-5472.CAN-10-1604. Epub 2010 Aug 31. Cancer Res. 2010. PMID: 20807803 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

418 results

Search Page

Filters